EverSource Wealth Advisors’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-562
Closed -$16.8K 4436
2025
Q3
$16.8K Buy
562
+4
+0.7% +$134 ﹤0.01% 2485
2025
Q2
$16.6K Buy
+558
New +$16.1K ﹤0.01% 2446
2025
Q1
Sell
-5
Closed -$198 4165
2024
Q4
$198 Buy
+5
New +$194 ﹤0.01% 3432
2022
Q3
Sell
-174
Closed -$6K 2124
2022
Q2
$6K Buy
+174
New +$6.75K ﹤0.01% 1222

Other funds holding SRDX

EverSource Wealth Advisors's SRDX Position: Q4 2025 in Review

EverSource Wealth Advisors sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 562 shares — an estimated $16.8K sold.

EverSource Wealth Advisors first reported a position in SRDX in Q2 2022 and held it in 4 quarters. The position peaked at $16.8K in Q3 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • EverSource Wealth Advisors reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • EverSource Wealth Advisors sold 562 Surmodics shares in Q4 2025, an estimated $16.8K.
  • EverSource Wealth Advisors first reported a position in Surmodics in Q2 2022 and held it in 4 quarters.
  • EverSource Wealth Advisors's Surmodics position peaked at $16.8K in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on EverSource Wealth Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.